Evaluation of Il-17 in Patients with Type II Diabetes Mellitus

Journal Title: International Journal of Health & Medical Research - Year 2024, Vol 3, Issue 12

Abstract

Background: Considering the probable engagement of Interleukin-17 in the development of DM, its possible eligibility as a diagnostic marker should be evaluated. Objectives: The aim of this study is to find out the role of IL-17 in the pathogenesis and diagnosis of diabetes mellitus. Methods: This case-control study was carried out at Al-Husseini Teaching Hospital, Karbala, Iraq, during the period from March to September 2024. The study included 50 diagnosed DM patients and 50 healthy controls. IL-17 levels were measured by ELISA using HuamaCount (Germany) kits. Results: Patients with DM were 48.67 ± 6.44 years old on average. The distribution of their ages was 24% from 35 to 44 years, 26% from 45 to 54 years, 18% from 55 to 64 years, and 32% from 65 to 74 years. For this male-to-female ratio, the DM group was 54:46 as compared to controls, which were 48:52. IL-17 levels were significantly higher in patients with DM (7.33 ± 1.54 pg/ml) than in the controls (5.48 ± 2.44 pg/ml) (P <0.0001). It gave an AUC of 0.63, sensitivity and specificity being 74% and 66% at a cutoff value of 6.33 pg/ml (P = 0.046), thus indicative of IL-17 as a fairly good diagnostic marker for DM. Conclusions: Elevated IL-17 levels may be involved in the pathogenesis of DM, of potential diagnostic and predictive utility as a biomarker though its modest discriminative ability calls for more research to buttress its usefulness in clinical practice.

Authors and Affiliations

Entisar Manfi Ahmed, Sahar Manfi Ahmed,

Keywords

Related Articles

The Role of Cytokines in Irritable Bowel Syndrome: Review Article

(IBS) or Irritable bowel syndrome is a complicated health condition with different causative factors, including inflammation and infection, that have recently acquired as significant triggers of IBS. Inflammatory respons...

Pathophysiology, The Biochemical and Clinical Significance of Lactate Dehydrogenase

Lactate dehydrogenase (LDH) is a family of enzymes that catalyzes oxidation-reduction enzymes, the interconversion between pyruvic acid and lactic acid. It is an enzyme that terminates the final catabolic reaction in whi...

Identification of Local Clusters of Hand Foot and Mouth Disease Based on Local Geary C Statistic

Background: Hand, foot, and mouth disease (HFMD) is a common childhood illness caused by enteroviruses. Increasingly, the disease has a substantial burden throughout Vietnam. To better understand of the epidemiology of...

Emerging Trends In Immunotherapy Management For Pancreatic Cancer: A Literature Review

The prognosis for pancreatic cancer (PC) is poor making it a substantial treatment challenge. A potentially effective treatment option is immunotherapy. To better understand the changing field of immunotherapy in PC mana...

Histopathological Changes in Pancreatic Cancer: A Review Article

Pancreatic cancer is one of the most fatal neoplasias worldwide due to diagnosis at a late stage and poor rates of survival. A highly aggressive neoplasm induces profound histopathological changes and complexity in the m...

Download PDF file
  • EP ID EP761554
  • DOI 10.58806/ijhmr.2024.v3i12n15
  • Views 24
  • Downloads 0

How To Cite

Entisar Manfi Ahmed, Sahar Manfi Ahmed, (2024). Evaluation of Il-17 in Patients with Type II Diabetes Mellitus. International Journal of Health & Medical Research, 3(12), -. https://europub.co.uk/articles/-A-761554